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Background: The accurate definition of organs at risk (OARs) is required to fully exploit the benefits of
intensity-modulated radiotherapy (IMRT) for head and neck cancer. However, manual delineation is
time-consuming and there is considerable inter-observer variability. This is pertinent as function-sparing and
adaptive IMRT have increased the number and frequency of delineation of OARs. We evaluated accuracy and
potential time-saving of Smart Probabilistic Image Contouring Engine (SPICE) automatic segmentation to
define OARs for salivary-, swallowing- and cochlea-sparing IMRT.
Methods: Five clinicians recorded the time to delineate five organs at risk (parotid glands, submandibular
glands, larynx, pharyngeal constrictor muscles and cochleae) for each of 10 CT scans. SPICE was then used to
define these structures. The acceptability of SPICE contours was initially determined by visual inspection and
the total time to modify them recorded per scan. The Simultaneous Truth and Performance Level Estimation
(STAPLE) algorithm created a reference standard from all clinician contours. Clinician, SPICE and modified
contours were compared against STAPLE by the Dice similarity coefficient (DSC) and mean/maximum distance
to agreement (DTA).
Results: For all investigated structures, SPICE contours were less accurate than manual contours. However, for
parotid/submandibular glands they were acceptable (median DSC: 0.79/0.80; mean, maximum DTA: 1.5 mm,
14.8 mm/0.6 mm, 5.7 mm). Modified SPICE contours were also less accurate than manual contours. The
utilisation of SPICE did not result in time-saving/improve efficiency.
Conclusions: Improvements in accuracy of automatic segmentation for head and neck OARs would be
worthwhile and are required before its routine clinical implementation.
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The accurate definition of organs at risk (OARs) is required
to fully exploit the benefits of intensity-modulated radio-
therapy (IMRT) for head and neck cancer [1]. However,
manual delineation is time-consuming [2]. There is also
considerable inter-observer variability; [3-6] which can re-
sult in significant differences in radiation dose to OARs [4].
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unless otherwise stated.interpretation of radiation effects; and meaningful compari-
sons between treatments. Standardisation is improved by
the use of contouring guidelines, multimodality imaging
and consensus between experts, but variation in organ de-
lineation remains [3,5,7]. This is of pressing importance
with the introduction of both function-sparing and adaptive
IMRT, where number and frequency of delineation of
OARs are increased.
Following head and neck radiotherapy, adverse late ef-
fects are highly prevalent and these impact on both
organ function and more general domains of well-being,
such as physical, mental and social health [8]. Radiation-ral Ltd. This is an Open Access article distributed under the terms of the Creative
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≥2 late side effect, which can result in difficulties with
speech, swallowing and dental caries [9-11]. Saliva is pro-
duced from the major (parotid, submandibular and sublin-
gual) and minor (soft palate, lips, cheeks) salivary glands
[12]. The parotid-sparing intensity-modulated versus con-
ventional radiotherapy in head and neck cancer (PAR-
SPORT) trial demonstrated the incidence of grade ≥2
xerostomia one year after treatment was significantly re-
duced with parotid-sparing IMRT compared to 3D-
conformal radiotherapy (38% versus 74%) [9]. One parotid
gland should be spared to a mean dose of less than 20Gy
or both glands to less than 25Gy [13]. For the subman-
dibular gland, relatively modest reductions in dose (to less
than 35Gy) may be of benefit [13].
Swallowing dysfunction is seen in up to half of patients
treated with definitive synchronous chemo-radiotherapy
and is the most common late grade ≥3 toxicity; the inci-
dence has increased with intensification of treatment in-
cluding addition of chemotherapy or altered fractionation
[14-16]. This adversely affects quality of life, probably to
an even greater extent than xerostomia [8,17-20]. The
mean radiation doses to the pharyngeal constrictor mus-
cles and supraglottic larynx are significantly associated
with late dysphagia [19,21-27]. The volume of the larynx
and pharyngeal constrictor muscles that receive a radi-
ation dose ≥60Gy (and where possible ≥50Gy) should be
minimised [28].
Permanent and predominantly high frequency sensori-
neural hearing loss may occur in 40-60% of patients who
receive radiotherapy to areas such as the nasopharynx,
para-nasal sinuses and parotid bed [29-31]. This is asso-
ciated with psychological and cognitive morbidity [32].
The mean dose to the cochlea should be limited to ≤45Gy
(or more conservatively ≤35Gy); and when combined with
cisplatin, strictly limited [33].
Significant anatomic changes and alteration in dose to
target volumes and OARs may occur during a course of
head and neck radiotherapy [34-37]. A standard way
to detect inter-fraction variation is volumetric ima-
ging using kilovoltage (kV) cone beam computed
tomography (CT) imaging. Typically these images are
superimposed on the planning CT scan using rigid co-
registration. However, this only allows qualitative com-
parison of similarity in six degrees of freedom, which
may not be adequate if the shapes or relative position of
target organs and OARs have changed. A potential solu-
tion for head and neck structures is the use of automatic
segmentation where the planning CT scan and manual
contours serve as an atlas and are mapped to the re-
planning or cone beam CT scan using a process of de-
formable registration and voxel-matching [36,38-41].
This would facilitate calculation of changes in doses to
the target volumes and OARs; [42] information thatcould be used to determine whether adaptive re-
planning is required [34,43-45].
Smart Probabilistic Image Contouring Engine (SPICE) is
an automated commercially available algorithm, which
combines an atlas-based and model-based approach to seg-
mentation of head and neck lymph node levels and OARs
[46]. The atlas was initially derived from expert ‘ground
truth’ contours. The automatic segmentation process em-
ploys multiple-steps of deformable image registration. First,
low-dimensional non rigid transformation maps the model
landmarks (or mean organ positions) into the image, which
accounts for any large displacements (atlas-based step).
Second, there is density-based registration where each voxel
is included or excluded from a structure depending on its
intensity (grey-scale step) i.e., functionality is limited to CT
scans. Third, a model-based segmentation approach is ap-
plied where organ models (‘meshes’) that have been created
from averaged manual expert segmentations adapts and re-
fines the structure (shape model-based step). This mesh
evolution can be considered as being ‘driven by the grey-
scale and constrained by the shape model’ [47].
This study aims to evaluate accuracy and time-saving
of SPICE to define OARs for salivary-, swallowing- and
cochlea-sparing IMRT.
Methods
Ten radiotherapy planning CT scans were selected where
the OARs of interest were not distorted by tumour or
artefact (treatment planning system, Pinnacle³ version
9.4). Five clinicians (four Consultants/Attending Physi-
cians and one Fellow) recorded for each scan the time to
manually delineate the parotid and submandibular glands,
larynx (supraglottic and glottic larynx defined as one
structure), pharyngeal constrictor muscles (superior, mid-
dle, inferior pharyngeal constrictor muscles and cricophar-
yngeus muscle defined as one structure) and cochleae
according to a locally agreed protocol based on published
guidelines (‘manual’ contours) [14,48,49]. SPICE was then
used to define these structures (‘SPICE’ contours). Each
clinician determined by visual inspection the acceptability
of SPICE contours for each structure and the total time to
modify these for each scan (‘modified SPICE’ contours).
The modified SPICE contours represent the utilisation of
SPICE in clinical practice (clinician review and modifica-
tion). These also demonstrate introduction of bias by
automatic segmentation (in the absence of bias, modified
and manual contours should ideally match).
The Simultaneous Truth and Performance Level Esti-
mation (STAPLE) algorithm employs a probability map to
create a ‘best fit’ from a collection of contours (Figure 1)
[50]. The STAPLE algorithm created a reference standard
from all clinician manual contours (‘STAPLE’ contours).
The manual, SPICE and modified SPICE contours were
compared to STAPLE by: Dice similarity coefficient (DSC)
Figure 1 Right parotid gland defined by five manual (multiple
colours) and one STAPLE (yellow) contour (one transverse CT
slice shown).
Table 1 SPICE version 1, 2 and 3 against STAPLE for
definition of parotid and submandibular glands; mean/
median values shown
SPICE contours n = 20 DSC mean DTA (mm) max DTA (mm)
Parotid Glands
1 0.77/0.79 2.2/1.9 19.0/17.4
2 0.78/0.79 1.6/1.5 14.7/14.8
3 0.72/0.75 3.3/2.5 21.5/19.8
Submandibular Glands
1 0.70/0.80 1.5/0.6 7.2/5.7
2 0.67/0.78 2.0/0.4 8.2/5.6
3 0.64/0.68 3.0/1.0 11.4/8.0
Abbreviations: DSC Dice similarity coefficient, DTA distance to agreement, max
maximum, mm millimetres, n number of SPICE 1, 2 or 3 contours for parotid or
submandibular glands (10 CT scans, two of each structure per scan) Parotid
gland ‘2’ and submandibular gland ‘1’ SPICE contours were taken forward for
subsequent investigation.
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DSC is a statistical measure of spatial overlap between
two structures. It is defined as 2x intersection volume/
total sum of volumes and normalises the degree of inter-
section from 0 (no overlap) to 1 (perfect overlap), with
good agreement defined as >0.7-0.8 [41,51,52]. DTA is a
geometrical parameter that measures the per voxel short-
est distance from the surface of one structure to another,
ideal = 0 mm. Paired structures (parotid glands, subman-
dibular glands and cochleae) were considered together.
For the parotid and submandibular glands, SPICE gener-
ated three contours (‘1’, ‘2’ or ‘3’), which were each based
on different ‘ground truth’ data [53]. Comparisons be-
tween these and STAPLE for all 10 patients were made to
determine the most accurate, for subsequent use and
evaluation. The study was conducted with appropriate
local R&D approval.
Statistical comparisons using multiple linear regression
analysis (to control for possible individual patient/scan
or clinician confounding factors) were made between
mean values of all matrices for: SPICE against STAPLE
versus manual against STAPLE (to determine the accur-
acy of SPICE); and modified SPICE against STAPLE ver-
sus manual against STAPLE (to determine the accuracy
of modified SPICE i.e., the utilisation of SPICE). As a
further measure of accuracy, SPICE was compared with
the most discordant clinician contours (determined
against STAPLE and by ranking of clinicians) for each
structure measured by DSC and DTA, using the Wil-
coxon signed rank test. The total times to manual versus
modify SPICE contours for all structures and clinicians
were compared using Student’s paired t-test (to deter-
mine efficiency in the utilisation of SPICE). Significance
was assessed at the p < 0.05 level.Results
Accuracy of SPICE
SPICE submandibular gland ‘1’ and parotid gland ‘2’ con-
tours demonstrated best concordance with STAPLE
(Table 1) and were used in subsequent comparisons.
The mean DSCs were significantly reduced for SPICE
contours compared with manual for all structures
(Figure 2). All SPICE contours were inferior to the most
discordant manual contours (Figure 2). However, for par-
otid and submandibular glands SPICE contours, the re-
spective median and interquartile ranges for DSCs were
0.79 (0.74, 0.83) and 0.80 (0.70, 0.85), suggesting accept-
ability for these structures. The mean and maximum
DTAs for SPICE contours and manual were similar for
parotid glands and cochleae but statistically significantly
worse for submandibular glands, larynx and pharyngeal
constrictor muscles (Figures 3 and 4). Similarly, except for
the parotid glands and cochleae, the SPICE contours mean
and maximum DTAs were inferior to the most discordant
clinician manual contours. However, for submandibular
glands, the respective median and interquartile ranges for
mean and maximum DTAs were relatively minor: 0.6 mm
(0.4-1.0) and 5.6 mm (4.7-8.2 mm).
Utilisation of SPICE
The total proportions of SPICE contours determined by
visual inspection not to require alteration were: parotid
glands (17%), submandibular glands (41%), larynx (8%),
pharyngeal constrictor muscles (4%), and cochleae (28%).
The mean DSCs were significantly reduced for modified
SPICE contours compared with manual for all structures
(Figure 5). However, the respective median and interquar-
tile ranges for modified SPICE DSCs for parotid glands,
submandibular glands and larynx were: 0.85 (0.83, 0.86),
0.85 (0.82, 0.87), and 0.76 (0.72, 0.82), which represented
Figure 2 Dice similarity coefficient - SPICE against STAPLE compared with: (i) all manual contours against STAPLE (left-side graphs); (ii)
individual clinicians manual contours against STAPLE (right-side graphs, statistical comparisons shown between most discordant clinician
contours against STAPLE versus SPICE against STAPLE) for A. parotid glands, B. submandibular glands, C. larynx, D. pharyngeal constrictor
muscles, E. cochleae. *p < 0.05, **p < 0.01, ***p < 0.001. Abbreviations: n, total number of manual or SPICE contours (for paired organs, two per scan).
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modified SPICE contours compared with manual were
similar for the pharyngeal constrictor muscles and coch-
leae but significantly worse for parotid glands, subman-
dibular glands and larynx (Figures 6 and 7). For these
three structures, the respective median and interquartile
ranges for the mean/maximum DTAs were 1.2 mm
(0.8 mm-1.7 mm)/10.6 mm (8.0 mm-14.8 mm), 0.4 mm
(0.2 mm-0.7 mm)/4.8 mm (4.0 mm-5.9 mm), 1.0 mm
(0.6 mm-1.6 mm)/9.3 mm (7.6-10.2), representing rela-
tively minor differences for submandibular glands.Efficiency in utilisation of SPICE
The respective per scan overall mean times for manual
and modified SPICE contours were 14.0 and 16.2 mi-
nutes (difference, 15.7%) (Figure 8). Only one out of five
clinicians showed a mean reduction in per scan overall
time to modify SPICE contours compared with manual.
Discussion
This study showed that for head and neck OARs: (i) SPICE
contours were less accurate than manual contours, but ac-
ceptable for the definition of parotid and submandibular
Figure 3 Mean Distance to Agreement (mm) - SPICE against STAPLE compared with: (i) all manual contours against STAPLE (left-side
graphs); (ii) individual clinicians manual contours against STAPLE (right-side graphs, statistical comparisons shown between most
discordant clinician contours against STAPLE versus SPICE against STAPLE) for A. parotid glands, B. submandibular glands, C. larynx,
D. pharyngeal constrictor muscles, E. cochleae. *p < 0.05, **p < 0.01, ***p < 0.001. Abbreviations: n, total number of manual or SPICE contours
(for paired organs, two per scan).
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manual contours; and (iii) the utilisation of SPICE com-
pared with manual delineation did not result in time-
saving/improve efficiency.
Automatic segmentation to define selected head and
neck OARs may reduce inter-observer variability [54,55].
Chao et al compared for two CT scans and eight clini-
cians, manual and automatic modified contours for de-
lineation of the clinical target volume as well as parotidglands, spinal cord, brainstem and (for one scan) the
optic apparatus [54]. For the OARs, inter-observer vari-
ability was significantly reduced for modified compared
with manual contours. This was associated with a mean
time saving of 26%-47%, which depended on experience
of the oncologist. In a subsequent study, the ISOgray
atlas-based auto-segmentation algorithm was evaluated
for definition of the brainstem, parotid glands and man-
dible [55]. The study was conducted at 2 centres, where
Figure 4 Maximum Distance to Agreement (mm) - SPICE against STAPLE compared with: (i) all manual contours against STAPLE (left-side
graphs); (ii) individual clinicians manual contours against STAPLE (right-side graphs, statistical comparisons shown between most
discordant clinician contours against STAPLE versus SPICE against STAPLE) for A. parotid glands, B. submandibular glands, C. larynx, D.
pharyngeal constrictor muscles, E. cochleae. *p < 0.05, **p < 0.01, ***p < 0.001. Abbreviations: n, total number of manual or SPICE contours (for
paired organs, two per scan).
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cians, 3 scans each) or modified automated contours (1
clinician, 7 scans); for only one scan were both manual
and modified contours defined. The mean DSCs for all
organs were 0.68 and 0.82 for manual and modified con-
tours, respectively; and the sensitivity and specificity for
manual versus modified contours were 63%-91% and
60%-80% versus 63-91% and 89-98%, respectively. These
results suggested reduced inter-observer variability for
modified contours compared with manual. However,while demonstration of reduced inter-observer variabil-
ity is important, it is not sufficient, because there is po-
tential introduction of bias and systematic errors.
The updated Brainlab automated segmentation algo-
rithm, which employs atlas-based and deformable regis-
tration, was assessed for accuracy of definition of neck
nodal regions and selected head and neck OARs [56]. In
10 ‘ideal’ cases without neck nodes on at least one side,
the ipsilateral parotid gland, spinal cord and brainstem
were contoured; and in 10 cases with neck node
Figure 5 Dice similarity coefficient – Modified SPICE against STAPLE compared with all manual contours against STAPLE for A. parotid
glands, B. submandibular glands, C. larynx, D. pharyngeal constrictor muscles, E. cochleae. *p < 0.05, **p < 0.01, ***p < 0.001.
Abbreviations: n, total number of manual or modified SPICE contours (for paired organs, two per scan).
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spinal cord, brainstem and mandible were defined. One
clinician manually contoured and then modified the auto-
matic contours for each scan/patient. The automatic and
modified contours were compared with manual contours
using the DSC as well as mean and maximum DTA. The
spinal cord and mandible contours were not included in
the analysis because the automatic contours did not re-
quire modification, except for mandible in one case. For
the second group of 10 cases, the OARs were considered
together. The authors found that except for spinal cord,
the automatic contours systematically required some
modification, with resultant improvement in DSC and
DTA measures. There was increased efficiency in defin-
ition of OARs with a reduction in mean time to manual
compared with modified contours from 11.2 minutes to
4.5 minutes (60%) and 16.4 to 6.3 minutes (62%), inrespective groups. This time-saving is partly due to the
automatic contours for spinal cord, brainstem and man-
dible requiring no or little modification.
Clinical validation of a multiple-subject atlas-based
autosegmentation tool was performed by measuring the
DSC and mean DTA for manual contours (outlined by
one of 10 clinicians and agreed by an expert panel) and
modified contours (outlined by one of two clinicians) for
neck levels, parotid and submandibular glands in 12 pa-
tients [57]. For manual versus automatic contours, the re-
spective DSC/mean DTA for parotid and submandibular
glands were 0.80/2.3 mm and 0.72/1.6 mm. For manual
versus modified automatic contours, the respective DSC/
mean DTA for parotid and submandibular glands were
0.81/2.1 mm and 0.77/1.2 mm.
We found that SPICE automatic contours were less ac-
curate/inferior to manual contours for all investigated
Figure 6 Mean Distance to Agreement (mm) – Modified SPICE against STAPLE compared with all manual contours against STAPLE for
A. parotid glands, B. submandibular glands, C. larynx, D. pharyngeal constrictor muscles, E. cochleae. *p < 0.05, **p < 0.01, ***p < 0.001.
Abbreviations: n, total number of manual or modified SPICE contours (for paired organs, two per scan).
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lar glands. For the parotid and submandibular glands, the
DSCs were satisfactory; [41,52] for parotid glands, the mean
and maximum DTAs were similar to manual contours and
for submandibular glands, the differences were relatively
minor. The modification of automatic contours improved
accuracy but remained inferior to manual contours and did
not result in time-saving. There are a number of possible
reasons for these findings. First, the processes of automatic
segmentation, both grey-scale and model-based are limited
by insensitivity to boundary or edge detection [47]. This is
important because the differences in attenuation between
soft tissues are often small and the shapes of organs diver-
gent. The computer-based algorithms do not account fornuances in the honed technique of the expert manual con-
tourer. Second, while there are published delineation guide-
lines for OARs, there is no agreed international consensus,
especially for definition of the larynx and pharyngeal con-
strictor muscles [14,48]. The SPICE atlas may have been
developed from dissimilar ‘ground truth’ contours. Where
available, an alternative investigational strategy would be to
adapt the local contouring protocol to that used to define
the atlas contours [58]. Third, to produce tightly conformed
volumes, relatively small alterations in automatic contours
may be required, which are time-consuming. The modifica-
tion process is then less efficient than manual delineation,
where techniques such as interpolation between CT slice
levels may be used.
Figure 7 Maximum Distance to Agreement (mm) – Modified SPICE against STAPLE compared with all manual contours against STAPLE
for A. parotid glands, B. submandibular glands, C. larynx, D. pharyngeal constrictor muscles, E. cochleae. *p < 0.05, **p < 0.01, ***p <
0.001. Abbreviations: n, total number of manual or modified SPICE contours (for paired organs, two per scan).
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modified contours result in clinically relevant alterations in
measured doses to OARs is uncertain. This will partly de-
pend on proximity of normal structures to the treatment
volume and the dose gradient. In this study, the target vol-
umes were not defined. This may have influenced the low
percentage of OARs determined by visual inspection not to
require alteration i.e., clinicians only considered the con-
formity of automatic contours to normal structures rather
than clinical relevance or requirement for this.This study represents an independent clinical evalu-
ation of automatic segmentation using SPICE and its
utilisation for head and neck OARs. It determined the
accuracy of SPICE by comparison against a reference
standard created using STAPLE, for five head and neck
OARs important in function-sparing IMRT. Future work
should evaluate automatic segmentation in the presence
of distortion by tumour or artefact e.g., dental amalgam;
and determine the variation in measured dose to OARs
between manual, automatic and modified contours.
AB
Figure 8 Efficiency in utilisation of SPICE - A. Total time per scan for all clinicians to manual and modify SPICE contours; and B. Time
differences per scan between modified SPICE contours compared with manual for each clinician. (positive values: increase in time to
modified versus manual contours); **p< 0.01. Abbreviations: n, total number of CT scans.
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For the investigated head and neck OARs, SPICE auto-
matic segmentations were less accurate than manual
contours. However, these were acceptable for the defin-
ition of parotid and submandibular glands. The modifi-
cation of SPICE contours improved accuracy, but these
remained inferior to manual contours and the process
did not result in time-saving. Improvements in auto-
matic segmentation of head and neck OARs would be
worthwhile and are required before routine clinical
implementation.Abbreviations
OARs: Organs at risk; IMRT: Intensity-modulated radiotherapy; SPICE: Smart
Probabilistic Image Contouring Engine; STAPLE: Simultaneous Truth and
Performance Level Estimation; DSC: Dice Similarity Coefficient; DTA: Distance
to agreement; PARSPORT: Parotid-sparing intensity modulated versus
conventional radiotherapy in head and neck cancer; Gy: Gray; kV: kilovoltage;
CT: Computed tomography.
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